Clinical Trials Directory

Trials / Completed

CompletedNCT01493648

Muscle-Related Side Effects of Statins: Functional Impact, Mechanisms, and Potential Relief With Vitamin D Supplementation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
CHU de Quebec-Universite Laval · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

This proposal will explore muscle function (strength and endurance) in men and women suffering from statin-induced muscle symptoms. The mechanisms responsible for these muscle symptoms will be explored. Also, the investigators will assess the potential usefulness of vitamin D supplementation in a randomized control trial.

Detailed description

Statins are a class of drugs that are widely prescribed to lower blood cholesterol levels. Although they have few side effects, many patients report muscle pain, cramps, and weakness when using these drugs. We know very little on the real impact of these muscle symptoms on patient quality of life, especially in relation to muscle strength and endurance. Patients under statin therapy will stop medication for 2 months. Results from blood sample, muscle function and muscle biopsy (in some participants) will be compared with baseline. Participants will then take vitamin D supplementation or placebo for one month. Thereafter, statin will be reintroduced for two months while continuing vitamin D or placebo supplementation. At the end of that time, measures from blood sample, muscle function and muscle biopsy will be compared with other visits.

Conditions

Interventions

TypeNameDescription
DRUGVitamin DParticipants will receive weekly doses of 30,000 IU of vitamin D for 3 months.
DRUGPlaceboParticipants will receive placebo (lactose 100 mg) for 3 months.

Timeline

Start date
2011-12-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2011-12-16
Last updated
2016-01-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01493648. Inclusion in this directory is not an endorsement.